Agios Pharm

NASDAQ AGIO

Data sourced from iex and EODHD
Download Data

Agios Pharm Income Statement 2011 - 2024

This table shows the Income Statement for Agios Pharm going from 2011 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31
Revenue
M 8 7 7 7 6 4 4 6 1 0 0 37 41 44 35 37 87 35 26 26 30 30 15 40 9 10 11 11 11 23 9 7 31 6 5 13 34 15 34 8 8 7 6 6 6 6 6 6 6 22
Cost of Revenue
M 2 2 1 1 1 0 1 0 0 0 - 1 1 1 1 1 1 0 0 0 0 1 1 87 78 98 89 94 76 78 71 62 54 46 45 45 39 41 30 26 20 19 17 14 13 12 11 12 11 38
Gross Profit
M 6 5 7 6 5 4 3 5 0 0 - 37 41 43 34 37 87 35 26 26 30 29 15 40 9 10 11 11 11 23 9 7 31 6 5 13 34 15 34 8 8 7 6 6 6 6 6 6 6 0
Operating Expenses
M 98 111 108 99 96 103 94 103 102 105 - 128 132 136 124 127 130 141 135 140 127 126 114 113 103 100 90 96 78 80 72 63 55 47 46 45 39 41 31 27 21 19 17 15 13 13 11 12 12 0
Selling, General, and Administrative Expenses (SG&A)
M 31 35 26 30 28 33 29 28 32 32 27 29 8 40 35 36 39 35 33 32 32 51 31 27 25 23 17 16 15 15 12 13 11 10 10 9 7 7 5 4 3 4 3 2 2 2 2 2 2 0
Research and Development (R&D) Expenses
M 67 76 82 69 67 70 65 75 70 73 64 62 58 96 90 91 91 106 102 107 96 94 83 87 78 77 73 80 63 65 61 51 44 37 36 36 32 35 26 23 17 15 15 13 11 11 10 10 10 31
Other Operating Expenses
M 0 0 0 0 0 0 0 0 0 0 - 37 66 0 0 0 0 0 0 0 0 -19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -31
Costs and Expenses
M 96 109 107 98 95 103 94 102 101 105 - 91 91 135 124 126 129 141 134 139 127 125 113 27 25 2 2 2 2 2 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 -38
Operating Income
M -92 -106 -101 -94 -91 -99 -91 -98 -101 -105 -91 -91 -91 -92 -90 -90 -43 -106 -109 -114 -97 -96 -99 -73 -94 -90 -79 -85 -67 -57 -64 -56 -24 -41 -40 -32 -5 -27 3 -18 -12 -12 -11 -9 -7 -6 -5 -6 -5 0
Interest Expense
M - - - - -10 6 4 2 1 0 0 0 0 6 10 2 3 4 3 4 4 5 4 4 3 2 2 2 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 11 10 1 2 10 136 9 6 6 6 7 9 0 -5 -9 0 3 4 3 4 4 5 4 4 3 2 2 2 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBT
M -82 -96 -91 -84 -81 37 -82 -92 -95 -99 -84 -83 -91 -98 -99 -90 -40 -102 -106 -110 -93 -92 -95 -69 -91 -88 -77 -83 -66 -56 -63 -56 -23 -41 -40 -32 -5 -27 3 -18 -12 -12 -11 -9 -7 -6 -5 -6 -5 0
Income Tax Provision
M - - -10 -10 -10 -136 -9 -6 -6 0 2 2 -13 -2 1 2 - -2 - - - -2 0 0 -2 -2 0 0 0 -2 0 -1 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 -1 0 -1 -1 7
Income after Tax
M - - -81 -74 -71 172 -72 -86 -88 -99 -87 -84 -78 -96 -100 -92 - -100 - - - -90 -95 -69 -89 -87 -77 -83 -66 -55 -63 -55 -22 -39 -39 -31 -5 -27 4 -18 -12 -12 -11 -9 -7 -5 -5 -6 -5 -7
Non-Controlling Interest
M - - 0 0 0 0 0 0 -3 -4 3 3 -1,965 6 10 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 2 0 0 0 0 0 0
Net Income
M - - -91 -84 -81 37 -82 -92 -95 -95 -89 -86 1,874 -98 -99 -90 -40 -102 -106 -110 -93 -92 -95 -69 -91 -88 -77 -83 -66 -56 -63 -56 -23 -41 -40 -32 -5 -27 4 -18 -12 0 -11 -10 0 0 0 0 0 0
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 56,383,475.00 55,897,860.00 55,803,663.00 55,604,330.00 55,265,390.00 54,789,435.00 54,844,579.00 54,799,680.00 54,555,467.00 54,335,230.00 57,048,175.00 61,066,977.00 69,543,510.00 69,271,163.00 69,144,061.00 68,958,091.00 68,608,279.00 63,949,870.00 58,803,534.00 58,722,244.00 58,453,918.00 58,189,254.00 58,033,386.00 57,721,786.00 55,694,603.00 48,772,901.00 48,459,424.00 46,745,760.00 42,280,525.00 42,110,541.00 38,548,153.00 37,956,383.00 37,864,084.00 37,660,033.00 37,507,298.00 37,329,220.00 37,214,747.00 35,121,705.00 36,592,683.00 33,602,472.00 31,395,000.00 31,153,000.00 22,744,486.00 30,127,620.00 23,389,580.00 23,389,580.00 23,389,580.00 23,389,580.00 23,389,580.00 -
EBITDA
M -91 -105 -101 -94 -91 -225 -94 -98 -101 -107 -91 -91 -89 -92 -87 -86 -41 -106 -107 -112 -95 -96 -97 -71 -94 -90 -77 -83 -65 -57 -62 -56 -24 -41 -40 -32 -5 -27 4 -18 -12 -12 -11 -8 -7 -6 -5 -6 -5 -
Depreciation and Amortization
M 1 1 2 2 2 -126 -2 0 0 2 2 2 2 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 -
EBIT
M -92 -106 -103 -96 -92 -99 -91 -98 -101 -110 -93 -93 -91 -94 -89 -88 -43 -108 -109 -114 -97 -98 -99 -73 -96 -92 -79 -85 -67 -59 -64 -58 -25 -42 -42 -33 -6 -27 3 -18 -13 -13 -11 -9 -7 -6 -5 -6 -5 0
Income from Discontinued Operations
M - - - - - - - - - 4 -5 -3 1,965 1,965 1,965 1,965 - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Tax Rate (Effective)
% - - 10.95 12.01 11.84 -371.51 11.43 6.35 6.72 -0.34 -2.68 -1.83 14.16 1.93 -1.13 -1.96 - 1.92 - - - 2.08 0.00 0.00 1.90 1.87 0.00 0.00 0.00 3.05 0.00 2.33 5.37 2.82 2.60 2.45 7.46 -0.08 -13.76 0.00 2.71 -1.38 -1.09 -1.16 -2.70 18.12 8.87 9.64 11.59 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% 75.88 72.00 91.44 83.49 90.12 90.42 85.30 92.21 59.25 98.29 - 98.19 98.30 97.82 98.16 98.19 99.39 99.19 98.49 98.84 98.90 97.66 95.43 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 0.00
Operating Income Margin
% -1,124.34 -1,496.23 -1,363.66 -1,396.01 -1,615.49 -2,300.97 -2,590.73 -1,749.19 -12,156.85 -253,144,168.08 - -244.26 -220.28 -209.86 -260.26 -241.51 -49.59 -298.90 -419.07 -434.24 -322.50 -321.05 -652.47 -180.50 -1,072.95 -919.79 -695.69 -745.64 -638.06 -253.48 -706.87 -809.26 -75.43 -657.72 -738.59 -243.08 -15.19 -182.61 9.46 -217.93 -146.05 -181.52 -176.60 -136.02 -112.41 -103.42 -81.53 -97.38 -83.98 0.00
Net Income Margin
% - - -1,234.27 -1,248.60 -1,444.43 847.47 -2,325.00 -1,644.68 -11,391.11 -228,512,436.61 - -230.85 4,526.37 -221.72 -285.19 -242.26 -46.22 -288.80 -407.98 -419.02 -307.93 -305.85 -622.87 -170.10 -1,036.58 -900.96 -679.14 -732.26 -629.67 -249.41 -699.32 -801.85 -74.16 -653.28 -734.62 -241.30 -14.49 -182.18 10.93 -217.52 -145.62 0.00 -169.27 -166.21 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA Ratio
% -1,107.88 -1,476.47 -1,363.66 -1,396.01 -1,615.49 -5,225.31 -2,660.75 -1,756.59 -12,184.01 -259,526,684.38 - -243.32 -214.30 -208.07 -250.13 -230.26 -46.75 -298.90 -411.07 -426.47 -315.87 -321.05 -640.64 -176.20 -1,072.95 -919.79 -681.48 -731.77 -622.92 -253.48 -690.88 -809.26 -75.43 -657.72 -738.59 -243.08 -15.19 -182.61 10.48 -214.04 -146.05 -181.52 -170.58 -130.06 -106.84 -98.28 -76.44 -93.03 -79.77 -
EBIT Ratio
% -1,124.34 -1,496.23 -1,385.59 -1,422.93 -1,647.41 -2,300.97 -2,590.73 -1,749.19 -12,156.85 -264,844,240.52 - -249.61 -220.28 -214.14 -257.05 -236.77 -49.59 -304.44 -419.07 -434.24 -322.50 -327.41 -652.47 -180.50 -1,092.64 -936.67 -695.69 -745.64 -638.06 -261.09 -706.87 -827.94 -79.41 -676.13 -757.70 -248.98 -16.27 -185.08 9.46 -217.93 -149.99 -186.57 -176.60 -136.02 -112.41 -103.42 -81.53 -97.38 -83.98 0.00
EBT Ratio
% -995.84 -1,350.70 -1,234.27 -1,248.60 -1,444.43 847.47 -2,325.00 -1,644.68 -11,391.11 -238,068,099.49 - -221.68 -219.46 -221.72 -285.19 -242.26 -46.22 -288.80 -407.98 -419.02 -307.93 -305.85 -622.87 -170.10 -1,036.58 -900.96 -679.14 -732.26 -629.67 -249.41 -699.32 -801.85 -74.16 -653.30 -734.62 -241.30 -14.49 -182.03 9.60 -217.52 -145.62 -181.09 -176.39 -135.94 -112.28 -103.30 -81.32 -97.03 -83.57 0.00

StockViz Staff

September 16, 2024

Any question? Send us an email